Results of Operations and Financial Condition. On October 29, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three and nine months ended September 30, 2026 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall…

Results of Operations and Financial Condition. On August 4, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three and six months ended June 30, 2026 (the “Second Quarter Release”). A copy of the Second Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not b…

Executive Vice President, General Counsel, Chief Administrative Officer and Secretary — Mary Ann E. Moore: Ms. Moore is transitioning from her roles and will depart the company on October 31, 2026.

Results of Operations and Financial Condition. On July 15, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release providing an update for the Company’s recently completed second quarter (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this

The excerpt is incomplete and does not provide sufficient information to determine the nature of the event.

Results of Operations and Financial Condition. On May 5, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months ended March 31, 2026 (the “First Quarter Release”). A copy of the First Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “fi…

Results of Operations and Financial Condition. On February 19, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2025 (the “Fourth Quarter Release”). A copy of the Fourth Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit…

Results of Operations and Financial Condition. On November 3, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2025 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1…

Other Events. On August 18, 2025, the Company announced that its Board of Directors has authorized a share repurchase program (the “Repurchase Program”) of up to $250 million of the Company’s outstanding common stock. The timing and actual number of shares repurchased will depend on a variety of factors, including market price of the shares, general business and market conditions, applicable legal requirements, and alternative investment opportunities. Repurchases under the Repurchase Program…

Regulation FD Disclosure. On August 18, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the share repurchase program described in

Results of Operations and Financial Condition. On August 5, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and six months ended June 30, 2025 (the “Second Quarter Release”). A copy of the Second Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shal…

Director — Dr. Kurt Newman: The filing discloses the appointment of a new director, which is a routine board composition change and not an executive departure.

Results of Operations and Financial Condition. On May 6, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months ended March 31, 2025 (the “First Quarter Release”). A copy of the First Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “fi…

Entry into a Material Definitive Agreement. On April 15, 2025, PMG Services, Inc. (“PMG Services”), a Florida corporation and wholly-owned subsidiary of Pediatrix Medical Group, Inc., and Guidehouse Managed Services LLC, a Delaware limited liability company (“Guidehouse”), agreed to amend Statement of Work #1 under that certain Master Services Agreement, dated as of April 19, 2024, between PMG Services and Guidehouse (as amended, the “Agreement”), to, among other things, extend the term from…

Results of Operations and Financial Condition. On February 20, 2025, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2024 (the “Fourth Quarter Release”). A copy of the Fourth Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit…

CEO — Mark S. Ordan: The filing discloses the appointment of a sitting Director and former CEO as the new CEO, representing an internal succession rather than the loss of an external executive.

Results of Operations and Financial Condition. The information set forth in

Executive Vice President, Chief Physician Executive — Dr. Curtis B. Pickert: The company terminated a senior executive (EVP/Chief Physician Executive) without cause, representing a significant loss of key management personnel.

Results of Operations and Financial Condition. On November 1, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2024 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1…

Results of Operations and Financial Condition. On August 6, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and six months ended June 30, 2024 (the “Second Quarter Release”). A copy of the Second Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shal…

CFO — C. Marc Richards: The CFO is being replaced by an internal promotion (SVP to CFO) in an orderly transition, which constitutes a succession rather than a sudden loss of a senior executive.

Executive Vice President — Lee A. Wood: The company eliminated the role of Executive Vice President, National and Market Operations, resulting in the termination of the incumbent without cause as part of an efficiency initiative.

Results of Operations and Financial Condition. On May 7, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months ended March 31, 2024 (the “First Quarter Release”). A copy of the First Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “fi…

Entry into a Material Definitive Agreement. On April 19, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), through PMG Services, Inc., a Florida corporation and wholly-owned subsidiary of the Company (“PMG Services”), entered into a Master Services Agreement (the “Agreement”) with Guidehouse Managed Services LLC (“Guidehouse”), a Delaware limited liability company, pursuant to which Guidehouse will provide certain enterprise revenue cycle management services for the…

Results of Operations and Financial Condition. On February 20, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2023 (the “Fourth Quarter Release”). A copy of the Fourth Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit…